Adverse effects of apraclonidine used in the diagnosis of Horner syndrome in infants.
Apraclonidine, a selective alpha(2)-agonist, was developed to lower intraocular pressure and minimize the systemic side effects associated with the use of its parent drug, clonidine.(1) An investigation of the site of action of apraclonidine incidentally uncovered a reversal of anisocoria in patients with absent sympathetic innervation of one pupil (Horner syndrome) due to its alpha(1)-effect on a pupil with denervation supersensitivity.(2) It has been used as a diagnostic test for Horner syndrome.(3,4) We report adverse effects of topical apraclonidine when used in the diagnosis of Horner syndrome in infants.
Watts
Patrick
P
Department of Ophthalmology, University Hospital of Wales, Cardiff, United Kingdom. patrickowatts@yahoo.co.uk <patrickowatts@yahoo.co.uk>
Satterfield
Denise
D
Lim
May Kim
MK
D000316:Adrenergic alpha-Agonists / Q000009:adverse effects*; D001919:Bradycardia / Q000139:chemically induced*; D003000:Clonidine / Q000009:adverse effects / Q000031:analogs & derivatives*; D004638:Emergency Treatment; D005260:Female; D006732:Horner Syndrome / Q000175:diagnosis*; D006801:Humans; D007223:Infant; D053609:Lethargy / Q000139:chemically induced*; D012120:Respiration Disorders / Q000139:chemically induced*; D012893:Sleep Wake Disorders / Q000139:chemically induced*
D000316:Adrenergic alpha-Agonists; C016986:apraclonidine; D003000:Clonidine